CSIMarket
 

Electromed Inc   (NYSEAMER: ELMD)

Electromed Inc 's

Competitiveness




 

ELMD Sales vs. its Competitors Q4 2026



Comparing the current results to its competitors, Electromed Inc reported Revenue increase in the 4 quarter 2026 by 8.97 % year on year.
The revenue growth was below Electromed Inc 's competitors' average revenue growth of 9.17 %, achieved in the same quarter.

List of ELMD Competitors

With a net margin of 17.52 % Electromed Inc achieved higher profitability than its competitors.

More on ELMD Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Electromed Inc Net Income in the 4 quarter 2026 grew year on year by 54.31%, faster than the Electromed Inc 's competitors .

<<  ELMD Stock Performance Comparisons


Electromed Inc 's Comment on Competition and Industry Peers


Enforcement actions related to FDA-regulated products include litigation by competitors concerning advertising and marketing claims. There is a risk of regulatory or enforcement actions, such as civil fines or criminal penalties, if promotional or training materials are found to promote unapproved uses. Comparable actions may also be taken by other federal, state, or foreign authorities.



  

Overall company Market Share Q4 2026

Revenue in Overall company grew by 8.97 %, less than Electromed Inc peers within this division.
<<  More on ELMD Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Electromed Inc




Resmed Inc
Share Performance



-13.07%
One Year



Resmed Inc
Profile

ResMed Inc is a medical equipment company focused on creating and manufacturing products for the treatment of sleep apnea and other respiratory conditions. Their business model includes a combination of direct sales and partnerships with healthcare providers, ensuring wide distribution of their devices to patients worldwide. By leveraging advanced technology and data-driven solutions, ResMed aims to enhance patient care and improve health outcomes for individuals with sleep-related breathing issues.

More about Resmed Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 34,330.153 mill. $ 5,504.590 mill. $ 1,519.566 mill.


Stereotaxis Inc
Share Performance



+3.38%
30 Days



Stereotaxis Inc
Profile

Stereotaxis Inc's business model involves developing and providing robotic technologies for use in medical procedures, particularly in the field of electrophysiology.

More about Stereotaxis Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 135.975 mill. $ 30.801 mill. $ -21.681 mill.


Profound Medical Corp
Share Performance



0.00%
Over The Past 5 Days



Profound Medical Corp
Profile

The company develops and markets AI-powered, MRI-guided medical devices designed for incision-free tissue ablation.

More about Profound Medical Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 246.824 mill. $ 18.814 mill. $ 8.444 mill.


Myomo Inc
Share Performance



+39.53%
One Year



Myomo Inc
Profile

Myomo Inc's business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.

More about Myomo Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 62.516 mill. $ 41.180 mill. $ -15.118 mill.


Inogen Inc
Share Performance



-17.89%
This Quarter



Inogen Inc
Profile

Inogen Inc is a medical device company that specializes in developing and manufacturing portable oxygen concentrators. Their business model involves designing and selling innovative oxygen therapy solutions directly to patients, healthcare providers, and home medical equipment providers. By eliminating the need for third-party distributors, Inogen Inc aims to provide cost-effective and accessible products that improve the quality of life for individuals relying on supplemental oxygen therapy.

More about Inogen Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 145.232 mill. $ 354.304 mill. $ -24.595 mill.

1 more competitors available

Sign in to see all competitors

Sources: Electromed Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Electromed Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.